MedPath

efficacy of extended- release methylphenidate on theory of mind ability of 7-9year old children with attention-deficit hyperactivity disorder

Phase 2
Conditions
Attention Deficit/ Hyperactivity Disorder.
Disturbance of activity and attentionAttention deficit:disorder with hyperactivityhyperactivity disordersyndrome with hyperactivityExcl.:hyperkinetic disorder associated with conduct disorder (F90.1)
F90.0
Registration Number
IRCT20190827044633N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Age between 7 and 9 years old - - -
Diagnostic and Statistical Manual-4 criteria for diagnosis of attention-deficit hyperactivity disorder
Parental consent to participate in research
Lack of history of medication for the disorder

Exclusion Criteria

Wechsler's IQ of less than 91 based on Wechsler's test - -
other major psychiatric illnesses including ASD
any physical defects that prevent tests, including severe visual and hearing impairment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Score in the Hutchin's Theory of Mind Questionnaire. Timepoint: At baseline and one month after treatment with long-acting methylphenidate. Method of measurement: Hutchin`s Theory of Mind Questionnaire.;Score in the TOM(Theory of Mind) test. Timepoint: At baseline and one month after treatment with long-acting methylphenidate. Method of measurement: TOM(Theory of Mind) test.;Score in Attention Deficit Hyperactivity Disorder Rating scale. Timepoint: At baseline and one month after treatment with long-acting methylphenidate. Method of measurement: Attention Deficit Hyperactivity Disorder Rating scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath